A secondary metabolite of Limosilactobacillus reuteri R2lc drives strain-specific pathology in a spontaneous mouse model of multiple sclerosis

Summary: Limosilactobacillus reuteri is an immunomodulatory bacterium enriched in non-industrialized microbiomes, making it a therapeutic candidate for chronic diseases. However, effects of L. reuteri strains in mouse models of multiple sclerosis have been contradictory. Here, we show that treatment...

Full description

Bibliographic Details

Published in:	Cell Reports
Main Authors:	Dale Archer, María Elisa Pérez-Muñoz, Stephanie Tollenaar, Simona Veniamin, Naomi Hotte, Christopher C. Cheng, Kristoff Nieves, Jee-Hwan Oh, Lilian Morceli, Susan Muncner, Daniel R. Barreda, Gurumoorthy Krishnamoorthy, Christopher Power, Jan-Peter van Pijkeren, Jens Walter
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Subjects:	CP: Microbiology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124725000920